Literature DB >> 21512143

IFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis.

Shui Ping Tu1, Michael Quante, Govind Bhagat, Shigeo Takaishi, Guanglin Cui, Xiang Dong Yang, Sureshkumar Muthuplani, Wataru Shibata, James G Fox, D Mark Pritchard, Timothy C Wang.   

Abstract

IFN-γ mediates responses to bacterial infection and autoimmune disease, but it is also an important tumor suppressor. It is upregulated in the gastric mucosa by chronic Helicobacter infection; however, whether it plays a positive or negative role in inflammation-associated gastric carcinogenesis is unexplored. To study this question, we generated an H(+)/K(+)-ATPase-IFN-γ transgenic mouse that overexpresses murine IFN-γ in the stomach mucosa. In contrast to the expected proinflammatory role during infection, we found that IFN-γ overexpression failed to induce gastritis and instead inhibited gastric carcinogenesis induced by interleukin-1beta (IL-1β) and/or Helicobacter infection. Helper T cell (Th) 1 and Th17 immune responses were inhibited by IFN-γ through Fas induction and apoptosis in CD4 T cells. IFN-γ also induced autophagy in gastric epithelial cells through increased expression of Beclin-1. Finally, in the gastric epithelium, IFN-γ also inhibited IL-1β- and Helicobacter-induced epithelial apoptosis, proliferation, and Dckl1(+) cell expansion. Taken together, our results suggest that IFN-γ coordinately inhibits bacterial infection and carcinogenesis in the gastric mucosa by suppressing putative gastric progenitor cell expansion and reducing epithelial cell apoptosis via induction of an autophagic program.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21512143      PMCID: PMC3139967          DOI: 10.1158/0008-5472.CAN-10-4009

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.

Authors:  V Shankaran; H Ikeda; A T Bruce; J M White; P E Swanson; L J Old; R D Schreiber
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

2.  T cell-mediated cytotoxicity via Fas/Fas ligand signaling in Helicobacter pylori-infected gastric corpus.

Authors:  S Ishihara; R Fukuda; K Kawashima; N Moriyama; H Suetsugu; N Ishimura; H Kazumori; T Kaji; H Sato; T Okuyama; K M Rumi; K Adachi; M Watanabe; Y Kinoshita
Journal:  Helicobacter       Date:  2001-12       Impact factor: 5.753

3.  Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon.

Authors:  P Sutton; T Kolesnikow; S Danon; J Wilson; A Lee
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

4.  Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori.

Authors:  Vittorio Necchi; Maria Elena Candusso; Francesca Tava; Ombretta Luinetti; Ulderico Ventura; Roberto Fiocca; Vittorio Ricci; Enrico Solcia
Journal:  Gastroenterology       Date:  2007-01-31       Impact factor: 22.682

5.  Induction of autophagy and inhibition of tumorigenesis by beclin 1.

Authors:  X H Liang; S Jackson; M Seaman; K Brown; B Kempkes; H Hibshoosh; B Levine
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

6.  Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma.

Authors:  Céu Figueiredo; José Carlos Machado; Paul Pharoah; Raquel Seruca; Sónia Sousa; Ralph Carvalho; Ana Filipa Capelinha; Wim Quint; Carlos Caldas; Leen-Jan van Doorn; Fátima Carneiro; Manuel Sobrinho-Simões
Journal:  J Natl Cancer Inst       Date:  2002-11-20       Impact factor: 13.506

Review 7.  Anti-inflammatory properties of pro-inflammatory interferon-gamma.

Authors:  Heiko Mühl; Josef Pfeilschifter
Journal:  Int Immunopharmacol       Date:  2003-09       Impact factor: 4.932

Review 8.  Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis.

Authors:  M Chawla-Sarkar; D J Lindner; Y-F Liu; B R Williams; G C Sen; R H Silverman; E C Borden
Journal:  Apoptosis       Date:  2003-06       Impact factor: 4.677

9.  CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice.

Authors:  Susan E Erdman; Theofilos Poutahidis; Michal Tomczak; Arlin B Rogers; Kathleen Cormier; Benjamin Plank; Bruce H Horwitz; James G Fox
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

10.  Deficiencies of GM-CSF and interferon gamma link inflammation and cancer.

Authors:  Thomas Enzler; Silke Gillessen; John P Manis; David Ferguson; James Fleming; Frederick W Alt; Martin Mihm; Glenn Dranoff
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  55 in total

1.  Interferon-γ directly induces gastric epithelial cell death and is required for progression to metaplasia.

Authors:  Luciana H Osaki; Kevin A Bockerstett; Chun F Wong; Eric L Ford; Blair B Madison; Richard J DiPaolo; Jason C Mills
Journal:  J Pathol       Date:  2019-01-24       Impact factor: 7.996

Review 2.  The hypothesis on function of glycosphingolipids and ABO blood groups revisited.

Authors:  Jerzy Kościelak
Journal:  Neurochem Res       Date:  2012-03-11       Impact factor: 3.996

3.  A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach.

Authors:  Christine P Petersen; Anne R Meyer; Carlo De Salvo; Eunyoung Choi; Cameron Schlegel; Alec Petersen; Amy C Engevik; Nripesh Prasad; Shawn E Levy; R Stokes Peebles; Theresa T Pizarro; James R Goldenring
Journal:  Gut       Date:  2017-02-14       Impact factor: 23.059

Review 4.  Dclk1-expressing tuft cells: critical modulators of the intestinal niche?

Authors:  Moritz Middelhoff; C Benedikt Westphalen; Yoku Hayakawa; Kelley S Yan; Michael D Gershon; Timothy C Wang; Michael Quante
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-07-06       Impact factor: 4.052

5.  Maturity and age influence chief cell ability to transdifferentiate into metaplasia.

Authors:  Victoria G Weis; Christine P Petersen; Jared A Weis; Anne R Meyer; Eunyoung Choi; Jason C Mills; James R Goldenring
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-11-23       Impact factor: 4.052

6.  The natural product phyllanthusmin C enhances IFN-γ production by human NK cells through upregulation of TLR-mediated NF-κB signaling.

Authors:  Youcai Deng; Jianhong Chu; Yulin Ren; Zhijin Fan; Xiaotian Ji; Bethany Mundy-Bosse; Shunzong Yuan; Tiffany Hughes; Jianying Zhang; Baljash Cheema; Andrew T Camardo; Yong Xia; Lai-Chu Wu; Li-Shu Wang; Xiaoming He; A Douglas Kinghorn; Xiaohui Li; Michael A Caligiuri; Jianhua Yu
Journal:  J Immunol       Date:  2014-08-13       Impact factor: 5.422

7.  Transgenic expression of interferon-γ in mouse stomach leads to inflammation, metaplasia, and dysplasia.

Authors:  Li-Jyun Syu; Mohamad El-Zaatari; Kathryn A Eaton; Zhiping Liu; Manas Tetarbe; Theresa M Keeley; Joanna Pero; Jennifer Ferris; Dawn Wilbert; Ashley Kaatz; Xinlei Zheng; Xiotan Qiao; Marina Grachtchouk; Deborah L Gumucio; Juanita L Merchant; Linda C Samuelson; Andrzej A Dlugosz
Journal:  Am J Pathol       Date:  2012-10-01       Impact factor: 4.307

Review 8.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma.

Authors:  Hye Won Chung; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 9.  The gastrointestinal tumor microenvironment.

Authors:  Michael Quante; Julia Varga; Timothy C Wang; Florian R Greten
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

10.  Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapy.

Authors:  Simone Kayser; Cristina Boβ; Judith Feucht; Kai-Erik Witte; Alexander Scheu; Hans-Jörg Bülow; Stefanie Joachim; Stefan Stevanović; Michael Schumm; Susanne M Rittig; Peter Lang; Martin Röcken; Rupert Handgretinger; Tobias Feuchtinger
Journal:  Oncoimmunology       Date:  2015-05-21       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.